Literature DB >> 9184878

Collision tumour of the ampulla of Vater: carcinoid and adenocarcinoma.

I M Williams1, N W Williams, D Stock, M E Foster.   

Abstract

Obstructive jaundice is most commonly due to luminal stones or lesions of the head of the pancreas and more rarely ampullary and primary common bile duct lesions. Obstruction due to lesions of the ampulla of Vater may be due to adenocarcinoma which has a significantly better long term prognosis than carcinomas located in the head of the pancreas. A case is presented where two tumours were identified at the ampulla of Vater of the resected specimen one an adenocarcinoma and the other a carcinoid tumour representing a collision tumour.

Entities:  

Mesh:

Year:  1997        PMID: 9184878      PMCID: PMC2423872          DOI: 10.1155/1997/46751

Source DB:  PubMed          Journal:  HPB Surg        ISSN: 0894-8569


  4 in total

1.  Collision tumor of the ampulla of Vater - Coexistence of neuroendocrine carcinoma and adenocarcinoma: report of a case.

Authors:  Hee Joon Kim; Byung Gwan Choi; Choong Young Kim; Chol Kyoon Cho; Jin Woong Kim; Jae Hyuk Lee; Young Hoe Hur
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2013-11-20

2.  Colliding / concomitant tumors of the intestine: report of 3 cases.

Authors:  Sebastian Mannweiler; Hans Peter Dinges; Christine Beham-Schmid; Hubert Hauser; Michael Starlinger; Sigrid Regauer
Journal:  Pathol Oncol Res       Date:  2003-10-07       Impact factor: 3.201

3.  Collision tumor in form of primary adenocarcinoma and neuroendocrine carcinoma of the duodenum.

Authors:  Lan Peng; Roderich E Schwarz
Journal:  Rare Tumors       Date:  2012-04-12

4.  A case study of a collision tumor composed of cancers of the bile duct and pancreas.

Authors:  Hideki Izumi; Daisuke Furukawa; Naoki Yazawa; Yoshihito Masuoka; Misuzu Yamada; Kosuke Tobita; Yohei Kawashima; Masami Ogawa; Yoshiaki Kawaguchi; Kenichi Hirabayashi; Toshio Nakagohri
Journal:  Surg Case Rep       Date:  2015-05-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.